USCA RIA’s GSK GSK Stock Holding History

USCA RIA’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-640	Closed	-$3K	–	374
2015 Q3	$3K	Buy	+640	New	+$33.3K	﹤0.01%	357

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

USCA RIA's GSK Position: Q2 2021 in Review

USCA RIA increased its GSK (GSK) stake by 6.1% in Q2 2021, buying an estimated $368K and bringing the position to 133,682 shares worth $6.65M. The position accounts for 0.4% of the portfolio, ranked #63.

USCA RIA first reported a position in GSK in Q2 2013 and has held it in 28 quarters since. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

USCA RIA held 133,682 shares of GSK worth $6.65M as of Q2 2021.
USCA RIA bought 7,661 GSK shares in Q2 2021, an estimated $368K.
GSK made up 0.4% of USCA RIA's portfolio in Q2 2021, its #63 holding.
USCA RIA first reported a position in GSK in Q2 2013 and has held it in 28 quarters since.
798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.